Back
Janux Therapeutics Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
56
JANX
Janux Therapeutics
Last Price:
$29.65
Seasonality Move:
-1.19%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and JANX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.84 | Buy |
20-day SMA: | 28.17 | Buy |
50-day SMA: | 31.86 | Sell |
200-day SMA: | 43.77 | Sell |
8-day EMA: | 28.38 | Buy |
20-day EMA: | 28.64 | Buy |
50-day EMA: | 32.49 | Sell |
200-day EMA: | 39.54 | Sell |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.01 | Sell |
Relative Strength Index (14 RSI): | 51.69 | Buy |
Chaikin Money Flow: | 288925 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.59 - 30.83) | Buy |
Bollinger Bands (100): | (29.97 - 53.27) | Sell |
Janux Therapeutics Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 29.69 while JANX 8-day simple moving average is 27.84, which is a Buy signal.
-
The stock price of JANX is 29.69 while Janux Therapeutics 20-day SMA is 28.17, which makes it a Buy.
-
Janux Therapeutics 50-day simple moving average is 31.86 while JANX share price is 29.69, making it a Sell technically.
-
JANX stock price is 29.69 and Janux Therapeutics 200-day simple moving average is 43.77, creating a Sell signal.
JANX Technical Analysis vs Fundamental Analysis
Buy
56
Janux Therapeutics (JANX)
is a Buy
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a BuyThe current Janux Therapeutics [JANX] share price is $29.69. The Score for JANX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Janux Therapeutics Stock Info
Market Cap:
1.8B
Price in USD:
29.69
Share Volume:
367.2K
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
22.52
Buy
56
Janux Therapeutics (JANX)
is a Buy
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 29.69 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is not overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 29.69 while JANX 8-day exponential moving average is 28.38, which is a Buy signal.
-
The stock price of JANX is 29.69 while Janux Therapeutics 20-day EMA is 28.64, which makes it a Buy.
-
Janux Therapeutics 50-day exponential moving average is 32.49 while JANX share price is 29.69, making it a Sell technically.
-
JANX stock price is 29.69 and Janux Therapeutics 200-day simple moving average is 39.54, creating a Sell signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.34 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.60 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is -1.01, suggesting Janux Therapeutics is a Sell
-
Janux Therapeutics Relative Strength Index (RSI) is 51.69, which suggest Janux Therapeutics is overbought
-
The Bollinger Bands (25) for Janux Therapeutics is (26.59 - 30.83), which suggest Janux Therapeutics is a Sell
-
The Bollinger Bands (100) for Janux Therapeutics is (29.97 - 53.27), which suggest Janux Therapeutics is a Sell
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.